Retatrutide and Autoimmune Disease: What Women Need to Know Before Trying This GLP-1 Triple Agonist
Retatrutide shows 24% weight loss in trials, but autoimmune considerations matter for women. Learn the risks, life-stage nuances, and pregnancy safety here.
Read clinical review